1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Introduction
2.2. Define: Research Objective
2.3. Determine: Research Design
2.4. Prepare: Research Instrument
2.5. Collect: Data Source
2.6. Analyze: Data Interpretation
2.7. Formulate: Data Verification
2.8. Publish: Research Report
2.9. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Cumulative Impact of COVID-19

6. Hepatitis Test Solution/Diagnosis Market, by Disease Type
6.1. Introduction
6.2. Hepatitis B (HBV)
6.3. Hepatitis C (HCV)

7. Hepatitis Test Solution/Diagnosis Market, by Technology
7.1. Introduction
7.2. Enzyme-linked Immunosorbent Assay (ELISA)
7.3. Isothermal Nucleic Acid Amplification Technology (INAAT)
7.4. Polymerase Chain Reaction (PCR)
7.5. Rapid Diagnostic Tests (RDT)

8. California Hepatitis Test Solution/Diagnosis Market

9. Florida Hepatitis Test Solution/Diagnosis Market

10. Illinois Hepatitis Test Solution/Diagnosis Market

11. New York Hepatitis Test Solution/Diagnosis Market

12. Ohio Hepatitis Test Solution/Diagnosis Market

13. Pennsylvania Hepatitis Test Solution/Diagnosis Market

14. Texas Hepatitis Test Solution/Diagnosis Market

15. Competitive Landscape
15.1. FPNV Positioning Matrix
15.1.1. Quadrants
15.1.2. Business Strategy
15.1.3. Product Satisfaction
15.2. Market Ranking Analysis
15.3. Market Share Analysis, By Key Player
15.4. Competitive Scenario
15.4.1. Merger & Acquisition
15.4.2. Agreement, Collaboration, & Partnership
15.4.3. New Product Launch & Enhancement
15.4.4. Investment & Funding
15.4.5. Award, Recognition, & Expansion

16. Company Usability Profiles
16.1. Abbott
16.2. Avantor Inc.
16.3. Bio-Rad Laboratories Inc.
16.4. bioMérieux SA
16.5. DiaSorin
16.6. F. Hoffmann-La Roche Ltd
16.7. FUJIREBIO Inc.
16.8. Grifols S.A.
16.9. Ortho Clinical Diagnostics
16.10. QIAGEN
16.11. Quest Diagnostics Incorporated
16.12. Siemens AG

17. Appendix
17.1. Discussion Guide
17.2. License & Pricing

List of Figures

FIGURE 1. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET: MARKET DYNAMICS
FIGURE 3. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2020 VS 2027 (%)
FIGURE 4. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2020 VS 2027 (USD MILLION)
FIGURE 5. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2027
FIGURE 6. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HEPATITIS B (HBV), 2018-2027 (USD MILLION)
FIGURE 7. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HEPATITIS B (HBV), BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 8. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HEPATITIS C (HCV), 2018-2027 (USD MILLION)
FIGURE 9. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HEPATITIS C (HCV), BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 10. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2020 VS 2027 (%)
FIGURE 11. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2020 VS 2027 (USD MILLION)
FIGURE 12. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2027
FIGURE 13. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA), 2018-2027 (USD MILLION)
FIGURE 14. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA), BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 15. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY (INAAT), 2018-2027 (USD MILLION)
FIGURE 16. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY (INAAT), BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 17. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2027 (USD MILLION)
FIGURE 18. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 19. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY RAPID DIAGNOSTIC TESTS (RDT), 2018-2027 (USD MILLION)
FIGURE 20. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY RAPID DIAGNOSTIC TESTS (RDT), BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 21. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET: FPNV POSITIONING MATRIX
FIGURE 22. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 23. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET, BY TYPE

List of Tables

TABLE 1. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2027 (USD MILLION)
TABLE 4. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HEPATITIS B (HBV), BY STATE, 2018-2027 (USD MILLION)
TABLE 5. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HEPATITIS C (HCV), BY STATE, 2018-2027 (USD MILLION)
TABLE 6. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2027 (USD MILLION)
TABLE 7. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA), BY STATE, 2018-2027 (USD MILLION)
TABLE 8. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY (INAAT), BY STATE, 2018-2027 (USD MILLION)
TABLE 9. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), BY STATE, 2018-2027 (USD MILLION)
TABLE 10. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY RAPID DIAGNOSTIC TESTS (RDT), BY STATE, 2018-2027 (USD MILLION)
TABLE 11. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET: SCORES
TABLE 12. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET: BUSINESS STRATEGY
TABLE 13. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET: PRODUCT SATISFACTION
TABLE 14. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET: RANKING
TABLE 15. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 16. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET: MERGER & ACQUISITION
TABLE 17. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 18. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 19. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET: INVESTMENT & FUNDING
TABLE 20. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 21. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET: LICENSE & PRICING

Companies Mentioned

Abbott
Avantor Inc.
Bio-Rad Laboratories Inc.
bioMérieux SA
DiaSorin
F. Hoffmann-La Roche Ltd
FUJIREBIO Inc.
Grifols S.A.
Ortho Clinical Diagnostics
QIAGEN
Quest Diagnostics Incorporated
Siemens AG